Parabilis Sets Biotech IPO Record - Poll - MDSpire

Parabilis Sets Biotech IPO Record

The clinical-stage cancer biotech raised $670 million in an upsized Nasdaq debut, with a further $75 million expected from a concurrent Regeneron private placement

  • June 15, 2026

  • 2 min

Share

Original Source(s)

Parabilis Sets Biotech IPO Record

  • June 15, 2026

Related Content

Case Report: ETV6 c.744del gene mutation acute lymphoblastic leukemia in identical twins

Radiomic analysis of the peritumoral zone identifies imaging signatures of glioma invasion associated with HSP70 expression

Primary malignant peripheral nerve sheath tumor of the liver: a case report and literature review